Literature DB >> 17350067

A TRIM5alpha-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry.

Mario Javier Pineda1, Brannon R Orton, Julie Overbaugh.   

Abstract

The replication of human immunodeficiency type-1 (HIV-1) is restricted in macaque cells, in part due to host factors that provide intrinsic immunity after entry. Here we show that a rhesus macaque epithelial cell line engineered to express human CD4, sMAGI cells, has at least two post-entry restrictions to HIV-1 replication: one that is dependent on a previously described post-entry restriction factor of macaque cells, TRIM5alpha, and another that is primarily TRIM5alpha-independent. The TRIM5alpha restriction, which was observed with particles that had an HIV-1 core pseudotyped with VSV-G envelope, is saturable and can be completely abrogated by introducing TRIM5alpha-specific siRNA into the cells. A similar TRIM5alpha-dependent restriction was observed when sMAGI cells expressing human CCR5 were infected with an R5-HIV-1. In contrast, even when viruses enter sMAGI cells using CD4 and an endogenous rhesus coreceptor at levels sufficient to saturate TRIM5alpha, they do not productively infect the sMAGI cells. Nor does treatment of sMAGI cells with TRIM5alpha-specific siRNA relieve this post-entry restriction; this was true whether the HIV-1 core was pseudotyped with SIV envelope or an R5-HIV-1 envelope. Together these data suggest that there is an alternate restriction to replication, here called Lv3, that is encountered by viruses that enter via interaction with CD4 and an endogenous rhesus coreceptor. Thus, these findings suggest that post-entry events are dependent upon the mechanism by which HIV-1 enters the cell.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350067      PMCID: PMC2743720          DOI: 10.1016/j.virol.2007.02.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2.

Authors:  D J Griffiths; M Dittmar; P Clapham; E Thomas
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.

Authors:  Matthew Stremlau; Michel Perron; Mark Lee; Yuan Li; Byeongwoon Song; Hassan Javanbakht; Felipe Diaz-Griffero; Donovan J Anderson; Wesley I Sundquist; Joseph Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-15       Impact factor: 11.205

3.  HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus.

Authors:  E Michelle Long; Stephanie M J Rainwater; Ludo Lavreys; Kishorchandra Mandaliya; Julie Overbaugh
Journal:  AIDS Res Hum Retroviruses       Date:  2002-05-20       Impact factor: 2.205

4.  Capsid is a dominant determinant of retrovirus infectivity in nondividing cells.

Authors:  Masahiro Yamashita; Michael Emerman
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  A dominant block to HIV-1 replication at reverse transcription in simian cells.

Authors:  Carsten Münk; Stephanie M Brandt; Ginger Lucero; Nathaniel R Landau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

6.  Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptors.

Authors:  Stefan Pöhlmann; Carl Davis; Silke Meister; George J Leslie; Claas Otto; Jacqueline D Reeves; Bridget A Puffer; Armin Papkalla; Mandy Krumbiegel; Andrea Marzi; Steffen Lorenz; Jan Münch; Robert W Doms; Frank Kirchhoff
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Lv2, a novel postentry restriction, is mediated by both capsid and envelope.

Authors:  Christian Schmitz; David Marchant; Stuart J D Neil; Keith Aubin; Sandra Reuter; Matthias T Dittmar; Aine McKnight
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 8.  Restriction factors: a defense against retroviral infection.

Authors:  Paul D Bieniasz
Journal:  Trends Microbiol       Date:  2003-06       Impact factor: 17.079

9.  Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism.

Authors:  Simone Cowan; Theodora Hatziioannou; Tshaka Cunningham; Mark A Muesing; Heinrich G Gottlinger; Paul D Bieniasz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-01       Impact factor: 11.205

10.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

View more
  16 in total

1.  RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction.

Authors:  Kelly M Marno; Eithne O'Sullivan; Christopher E Jones; Julieta Díaz-Delfín; Claire Pardieu; Richard D Sloan; Áine McKnight
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

2.  A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection.

Authors:  Daryl Humes; Sandra Emery; Elizabeth Laws; Julie Overbaugh
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

3.  The role of amino acid changes in the human immunodeficiency virus type 1 transmembrane domain in antibody binding and neutralization.

Authors:  Erica Lovelace; Hengyu Xu; Catherine A Blish; Roland Strong; Julie Overbaugh
Journal:  Virology       Date:  2011-10-24       Impact factor: 3.616

4.  Adaptation of subtype a human immunodeficiency virus type 1 envelope to pig-tailed macaque cells.

Authors:  Daryl Humes; Julie Overbaugh
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

5.  Novel postentry resistance to AKV ecotropic mouse gammaretroviruses in the African pygmy mouse, Mus minutoides.

Authors:  Yuhe Yan; Christine A Kozak
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

6.  A variant macaque-tropic human immunodeficiency virus type 1 is resistant to alpha interferon-induced restriction in pig-tailed macaque CD4+ T cells.

Authors:  Rajesh Thippeshappa; Hongmei Ruan; Weiming Wang; Paul Zhou; Jason T Kimata
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

7.  A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.

Authors:  Nidia M M Oliveira; Roochi Trikha; Áine McKnight
Journal:  Retrovirology       Date:  2010-10-07       Impact factor: 4.602

8.  HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.

Authors:  Jennifer Mabuka; Ruth Nduati; Katherine Odem-Davis; Dylan Peterson; Julie Overbaugh
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

9.  HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response.

Authors:  Valerie Cortez; Katherine Odem-Davis; R Scott McClelland; Walter Jaoko; Julie Overbaugh
Journal:  PLoS Pathog       Date:  2012-03-29       Impact factor: 6.823

10.  Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration.

Authors:  Massimo Pizzato; Sean Matthew McCauley; Martha R Neagu; Thomas Pertel; Claudia Firrito; Serena Ziglio; Ann Dauphin; Madeleine Zufferey; Lionel Berthoux; Jeremy Luban
Journal:  PLoS Pathog       Date:  2015-07-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.